Description
Cell line name NCC-MFS5-C1
Accession CVCL_B5YX
Resource Identification Initiative To cite this cell line use: NCC-MFS5-C1 (RRID:CVCL_B5YX)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 91.7 hours (PubMed=35053323).
Omics: SNP array analysis.
Derived from site: In situ; Right elbow, hypodermis; UBERON=UBERON_0001461+UBERON_0002072.
Sequence variations
Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=35053323).
Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (PubMed=35053323).
Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (PubMed=35053323).
Disease Myxofibrosarcoma (NCIt: C6496)
Myxofibrosarcoma (ORDO: Orphanet_79105)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 60Y
Category Cancer cell line
STR profile
Source(s): PubMed=35053323
Markers:
Amelogenin | X,Y |
CSF1PO | 11 |
D5S818 | 11 |
D7S820 | 11,12 |
D13S317 | 11 |
D16S539 | 9 |
D21S11 | 30,32 |
TH01 | 8,9 |
TPOX | 8 |
vWA | 15,18 |
Publications
PubMed=35053323; DOI=10.3390/cells11020207
Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Akiyama T., Sugaya J., Kobayashi E., Kojima N., Yoshida A., Ohtori S., Kawai A., Kondo T.
Establishment and characterization of NCC-MFS5-C1: a novel patient-derived cell line of myxofibrosarcoma.
Cells 11:207.1-207.13(2022)
Cross-references
Encyclopedic resources Wikidata; Q112129415
Reviews
There are no reviews yet.